Scientific Program

Below preliminary program is setting the themes for submitting papers. Once papers have been accepted a detailed program will be published. Some keynote speakers are already being listed. Please note that the titles of their presentations are preliminary working titles and might be subject to change.

There will be an exiting post-conference “Dupuytren Research Hackaton” on 8 September! We will have presentations and practical demonstrations from leading researchers in the field of Dupuytren disease. These will include clinicians, epidemiologists, data scientists, and experts on patient reported outcomes. We plan to ask an unanswered research question at the start of the day, and using our access to a wide variety of research databases answer the question by the end of the day. By the end of the week, we hope to have a paper ready for submission to a journal!

Themes for the International Dupuytren Conference in Oxford, 6/7 September 2021:

Basic Research

Anatomy

Pathology and Pathogenesis

Keynote Speaker: Dr. Charles Eaton, Dupuytren Research Group, West Palm Beach, USA
Biomarkers and the International Dupuytren Databank

Genetics

Keynote Speaker: Prof. Dominic Furniss, Botnar Research Centre, Oxford, UK
Advances in genetic analysis of fibrosis

Cell Biology

Keynote Speaker: Prof. David O’Gorman, Lawson Health Research Institute, London, Canada
Advances in the cellular biology of fibrosis

Epidemiology and Economic Aspects

Current Clinical Treatments

Surgical Interventions

Keynote Speaker: Dr Joakim Strömberg, Sahlgrenska University Hospital, Sweden
Randomised controlled trials in Dupuytren Disease

Collagenase Injection

Keynote Speaker: Prof. David Warwick, University Hospital Southampton, UK
Collagenase – current status, future prospects

Percutaneous Needle Fasciotomy (PNF)

Keynote Speaker: Prof. Paul Werker, UMCG, University of Groningen, The Netherlands
Difficult clinical cases

Radiotherapy

Keynote Speaker: Dr. Richard Shaffer, The Dupuytren’s Practise, London, UK
Radiotherapy for Dupuytren Disease

Clinical Experience and Trials of Specific Treatments

Keynote Speaker: Prof. Jagdeep Nanchahal, Kennedy Institute of Rheumatology, Oxford, UK
Re-purposing anti-TNF for Dupuytren’s Disease

Hand Therapy and New Therapies

Hand Therapy

Splinting

New Concepts and Treatments

Keynote Speaker: Prof. Andrew Leask, University of Western Ontario, Canada
What are the best prospects for drug repurposing in Dupuytren Disease?

Measurement and Patient’s Experience

Measurement Techniques

Patient Reported Outcome Measurements

Patient’s Experience and Requirements

Keynote Speaker: Wolfgang Wach, PhD, International Dupuytren Society, Übersee, Germany
International Patient Societies

Related Fibromatoses

Ledderhose Disease

Knuckle Pads

Peyronie Disease